An RNA Alternative to Human Transferrin: A New Tool for Targeting Human Cells
Open Access
- 1 January 2012
- journal article
- Published by Elsevier BV in Molecular Therapy Nucleic Acids
- Vol. 1 (5), e21
- https://doi.org/10.1038/mtna.2012.14
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- A General RNA Motif for Cellular TransfectionMolecular Therapy, 2012
- Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based MechanismsMolecular Therapy, 2010
- Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticlesNature, 2010
- Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumorsNature Biotechnology, 2009
- Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA–PEG nanoparticlesProceedings of the National Academy of Sciences of the United States of America, 2008
- Aptamer-based endocytosis of a lysosomal enzymeProceedings of the National Academy of Sciences of the United States of America, 2008
- Novel Dual Inhibitory Function Aptamer–siRNA Delivery System for HIV-1 TherapyMolecular Therapy, 2008
- Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imagingProceedings of the National Academy of Sciences of the United States of America, 2007
- Blood–Brain Barrier Transport of Therapeutics via Receptor-MediationPharmaceutical Research, 2007
- Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivoProceedings of the National Academy of Sciences of the United States of America, 2006